Successful eradication of genotype 4 HCV with telaprevir-based triple antiviral therapy

被引:0
|
作者
Deneke, M. G. [1 ]
Dranoff, J. A. [1 ,2 ]
Duarte-Rojo, A. [1 ]
机构
[1] Univ Arkansas Ciencias Med, Div Gastroenterol & Hepatol, 4301 W Markham 567, Little Rock, AR 72205 USA
[2] Arkansas Cent, Serv Invest, Serv Salud Vet Affairs, Little Rock, AR USA
来源
关键词
D O I
10.1016/j.rgmx.2013.09.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:64 / 66
页数:4
相关论文
共 50 条
  • [31] Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis C
    Hiramine, Satoshi
    Furusyo, Norihiro
    Ogawa, Eiichi
    Nakamuta, Makoto
    Kajiwara, Eiji
    Nomura, Hideyuki
    Dohmen, Kazufumi
    Takahashi, Kazuhiro
    Satoh, Takeaki
    Azuma, Koichi
    Kawano, Akira
    Koyanagi, Toshimasa
    Kotoh, Kazuhiro
    Shimoda, Shinji
    Hayashi, Jun
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (26) : 2688 - 2695
  • [32] Efficacy and factors associated with SVR in telaprevir-based triple therapy in hepatitis C patients
    Sasaki, Masato
    Tanaka, C.
    Obata, Masahiro
    Takeguchi, Masataka
    Matsushita, Hiroshi
    Yoshida, Kenichi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 202 - 203
  • [33] Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis C
    Satoshi Hiramine
    Norihiro Furusyo
    Eiichi Ogawa
    Makoto Nakamuta
    Eiji Kajiwara
    Hideyuki Nomura
    Kazufumi Dohmen
    Kazuhiro Takahashi
    Takeaki Satoh
    Koichi Azuma
    Akira Kawano
    Toshimasa Koyanagi
    Kazuhiro Kotoh
    Shinji Shimoda
    Jun Hayashi
    World Journal of Hepatology, 2015, (26) : 2688 - 2695
  • [34] Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C
    Kohjima, Motoyuki
    Kurokawa, Miho
    Enjoji, Munechika
    Yoshimoto, Tsuyoshi
    Nakamura, Tsukasa
    Ohashi, Tomoko
    Fukuizumi, Kunitaka
    Harada, Naohiko
    Murata, Yusuke
    Matsunaga, Kazuhisa
    Kato, Masaki
    Kotoh, Kazuhiro
    Nakamuta, Makoto
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (05) : 1781 - 1787
  • [35] Evaluation of factors associated with relapse in telaprevir-based triple therapy for chronic hepatitis C
    Kondo, C.
    Atsukawa, M.
    Tsubota, A.
    Shimada, N.
    Abe, H.
    Aizawa, Y.
    JOURNAL OF POSTGRADUATE MEDICINE, 2016, 62 (01) : 20 - 25
  • [36] The Effect of Telaprevir-Based Triple Therapy for Chronic Hepatitis C Patients on Gastric Emptying
    Arai, Makoto
    Oyamada, Arata
    Maruoka, Daisuke
    Matsumura, Tomoaki
    Nakagawa, Tomoo
    Kanda, Tastuo
    Katsuno, Tatsuro
    Imazeki, Fumio
    Yokosuka, Osamu
    GASTROENTEROLOGY, 2014, 146 (05) : S615 - S616
  • [37] Effect of telaprevir-based triple therapy on the renal function of chronic hepatitis C patients
    Ozeki, Itaru
    Nakzima, Tomoaki
    Hige, Shuhei
    Karino, Yoshiyasu
    HEPATOLOGY, 2012, 56 : 1040A - 1040A
  • [38] Impact of IL28B genotype on first-week response to telaprevir-based therapy in HIV-HCV coinfection
    Neukam, Karin
    Munteanu, Daniela
    Haubitz, Sebastian
    Mira, Jose A.
    Ingiliz, Patrick
    Rivero-Juarez, Antonio
    Lutz, Thomas
    de los Santos-Gil, Ignacio
    Scholten, Stefan
    Marquez, Manuel
    Rauch, Andri
    Rockstroh, Juergen K.
    Pineda, Juan A.
    ANTIVIRAL THERAPY, 2015, 20 (04) : 407 - 413
  • [39] Management of telaprevir-based triple therapy for hepatitis C virus recurrence post liver transplant
    Kerstin Herzer
    Angela Papadopoulos-Khn
    Anne Achterfeld
    Ali Canbay
    Katja Piras-Straub
    Andreas Paul
    Andreas Walker
    Jrg Timm
    Guido Gerken
    World Journal of Hepatology, 2015, (09) : 1287 - 1296
  • [40] Management of telaprevir-based triple therapy for hepatitis C virus recurrence post liver transplant
    Herzer, Kerstin
    Papadopoulos-Koehn, Angela
    Achterfeld, Anne
    Canbay, Ali
    Piras-Straub, Katja
    Paul, Andreas
    Walker, Andreas
    Timm, Joerg
    Gerken, Guido
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (09) : 1287 - 1296